GO
Loading...

Intercept's drug could do billions a year: Analyst

Friday, 10 Jan 2014 | 2:42 PM ET

Shares of Intercept Pharmaceuticals are up more than 560 percent this week alone. Akiva Felt, Oppenheimer senior analyst, shares his optimistic view for the company.